Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

IXICO PLC

PHYOY:US

Ticker Delisted

Snapshot for IXICO PLC (PHYOY)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for PHYOY

No chart data available.
  • PHYOY:US
  • 1M
  • 1Y
0.0000
Interactive PHYOY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PHYOY

Current P/E Ratio (ttm) -
Estimated P/E(09/2014) -
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (09/2014) -0.0060
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 7.48
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0458
Dividend Ex-Date 04/04/2014
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PHYOY

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for PHYOY

IXICO plc offers technologies for researching, diagnosing and treating serious diseases with a focus on neuro-degeneration. The technologies include medical image management and analysis products to assess the safety and efficacy of drugs in development. The Company's proprietary technologies TrialWire(tm) and TrialTracker(tm) have been used in clinical trials of Alzheimer's treatments.

Derek HillChief Executive OfficerSusan Day LowtherChief Financial Officer
Jane WhitrowVP:Business Ops/SecretaryJohn HallVP:Business Development
More Company Profile & Key Executives for PHYOY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil